Parkinson’s Disease

pddti — Bi-Lateral Injection of 6-Hydroxydopamine into the Substantia Nigra Pars Compacta

The objective of this pilot preclinical work is to evaluate the therapeutic impact of a new iron-chelating agent on long-term motor disabilities in a toxin-induced rodent model of Parkinson’s disease.